Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-11-01

FDA Approved: VOQUEZNA — Original Application (Phathom Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves Voquezna (vonoprazan fumarate) from Phathom Pharmaceuticals as an original application for the treatment of Helicobacter pylori infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VOQUEZNA (vonoprazan fumarate)

Snippet

ORIG AP for VOQUEZNA (VONOPRAZAN FUMARATE)